Neonatal Exposure to Amoxicillin Alters Long-Term Immune Response Despite Transient Effects on Gut-Microbiota in

Janelle M Fouhse1, Kaiyuan Yang1, Juan More-Bayona2

  • 1Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, AB, Canada.

Frontiers in Immunology
|September 26, 2019
PubMed

Insights

Early antibiotic exposure in neonatal pigs, even at therapeutic doses, can program the immune system for long-term changes. Despite transient gut microbe disruption, pigs showed heightened immune responses to challenges later in life.

Area of Science:

  • Immunology
  • Microbiology
  • Neonatal Development

Background:

  • Neonatal antibiotic exposure can disrupt the gut microbiome and impact immune system development.
  • Understanding the long-term effects of early-life antibiotic use on immune competence is crucial.

Purpose of the Study:

  • To investigate the effects of early-life amoxicillin exposure on immune cell phenotype, microbial composition, and immune response in neonatal pigs.
  • To determine if therapeutic antibiotic doses during development have lasting impacts on immune function.

Main Methods:

  • Newborn pigs received amoxicillin (AB) or placebo (PL) from post-natal day (PND) 0-14.
  • Evaluated fecal microbial composition, peripheral blood mononuclear cell (PBMC) subtypes, and IFNγ production.
  • Assessed immune response to a *Salmonella enterica* serovar Typhimurium challenge.

Main Results:

  • Amoxicillin exposure transiently altered fecal microbial composition, increasing Enterobacteriaceae.
  • Significant differences in PBMC subtypes (CD3+CD4+ T cells, naive T cells) were observed.
  • Amoxicillin-treated pigs showed enhanced IFNγ production and neutrophil activation following immune challenge.

Conclusions:

  • Early-life, therapeutically relevant amoxicillin exposure has a programming effect on the neonatal immune system.
  • Despite transient microbial disruption, antibiotic exposure leads to long-term alterations in immune responsiveness.
  • This study highlights potential adverse immune outcomes associated with early-life antibiotic use.